ACCELERATE Annual Conference 2023
Are you ready for the 11th ACCELERATE Annual Conference? We are back to in-person events, and we want to resume stronger than ever!
Join us in a completely new venue in Brussels to network, share knowledge and engage with our international, multi-stakeholder community on the latest in paediatric oncology drug development.
CTA register today: https://www.accelerate-platform.org/annual-conference-2023
Aladdin - The new educational programme on strategic and regulatory science in paediatric oncology drug development
Registration will open soon:
- Course on Strategic/Regulatory Science in Paediatric Oncology Drug Development
- 360º Multi-stakeholder Rotation at the European Medicines Agency (EMA) and/or pharmaceutical industry (Roche or Sanofi)
- Research Fellowship at ACCELERATE
The Educational Training Platform is also under way. Stay tuned...
CTA learn more: https://www.accelerate-platform.org/aladdin
Webinar series ‘Improving academia-industry collaborative trials’
Academic trials are not usually part of the marketing authorisation process of a new drug. Why is that? Let’s explore how we can open up this opportunity to enable academia-industry collaborative trials to deliver data that can be used for licensing purposes (fit for filing).
CTA join webinars: https://www.accelerate-platform.org/fff-webinars
The Critical Role of Academic Clinical Trials in Paediatric Cancer Drug Approvals
Transparent collaboration and knowledge sharing between the partners opens an important pathway for accelerating new treatments into clinical practice for children with cancer. Learn more about collaboration between industry and academic investigators in this new manuscript led by the ACCELERATE Fit For Filing Working Group.
CTA read it today: https://ascopubs.org/doi/full/10.1200/JCO.22.00033